Cytochrome P450 pathways of arachidonic acid metabolism

被引:162
作者
Kroetz, DL
Zeldin, DC
机构
[1] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA
[2] Univ Calif San Francisco, Sch Pharm, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
D O I
10.1097/00041433-200206000-00007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450s metabolize arachidonic acid to hydroxyeicosatetraenoic acids and epoxyeicosatrienoic acids. These eicosanoids are formed in a tissue and cell-specific manner and have numerous biological functions. Of major interest are the opposing actions of hydroxyeicosatetraenoic and epoxyeicosatrienoic acids within the vasculature. Regio- and stereoisomeric epoxyeicosatrienoic acids have potent vasodilatory proper-ties while 20-hydroxyeicosatetraenoic acid is a potent vasoconstrictor. Both effects are mediated through actions on large-conductance Ca2+-activated K+ channels. Cytochrome P450-derived eicosanoids are also important in the regulation of ion transport, and have recently been shown to influence a number of fundamental biological processes including cellular proliferation, apoptosis, inflammation, and hemostasis. The formation of these functionally relevant eicosanoids is tightly controlled by the expression and activity of the cytochrome P450 epoxygenases and hydroxylases. In addition, soluble epoxide hydrolase catalyzes the hydrolysis of epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids, and the activity of this enzyme is a critical determinant of tissue epoxyeicosatrienoic and dihydroxyeicosatrienoic acid levels. The intracellular balance between epoxyeicosatrienoic, dihydroxyeicosatrienoic and hydroxyeicosatetraenoic acids influences the biological response to these eicosanoids and alterations in their levels have recently been associated with certain pathological conditions. The involvement of the cytochrome P450-derived ecosanoids in a wide array of biological functions and the observation that levels are altered in pathological conditions suggest that the enzymes involved in the formation and degradation of these fatty acids may be novel therapeutic targets. Curr Opin Lipidol 13:273-283. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:273 / 283
页数:11
相关论文
共 120 条
[1]   16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes [J].
Bednar, MM ;
Gross, CE ;
Balazy, MK ;
Belosludtsev, Y ;
Colella, DT ;
Falck, JR ;
Balazy, M .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (03) :447-455
[2]   16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocytes and reduces intracranial pressure in a rabbit model of thromboembolic stroke [J].
Bednar, MM ;
Gross, CE ;
Russell, SR ;
Fuller, SP ;
Ahern, TP ;
Howard, DB ;
Falck, JR ;
Reddy, KM ;
Balazy, M .
NEUROSURGERY, 2000, 47 (06) :1410-1418
[3]   EETs relax airway smooth muscle via an EpDHF effect:: BKCa channel activation and hyperpolarization [J].
Benoit, C ;
Renaudon, B ;
Salvail, D ;
Rousseau, E .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (05) :L965-L973
[4]   P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D-aspartate [J].
Bhardwaj, A ;
Northington, FJ ;
Carhuapoma, JR ;
Falck, JR ;
Harder, DR ;
Traystman, RJ ;
Koehler, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (04) :H1616-H1624
[5]   Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue [J].
Birks, EK ;
Bousamra, M ;
Presberg, K ;
Marsh, JA ;
Effros, RM ;
Jacobs, ER .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (05) :L823-L829
[6]  
Brand-Schieber E, 2000, J PHYSIOL PHARMACOL, V51, P655
[7]   cDNA cloning and expression of CYP4F12, a novel human cytochrome P450 [J].
Bylund, J ;
Bylund, M ;
Oliw, EH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (03) :892-897
[8]  
Campbell W B, 2001, Med Sci Monit, V7, P578
[9]   New role for epoxyeicosatrienoic acids as anti-inflammatory mediators [J].
Campbell, WB .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (04) :125-127
[10]  
Capdevila JH, 2000, J LIPID RES, V41, P163